Impilo Funding: How Much Did They Raise & Key Investors

How Much Did Impilo Raise?
Funding & Key Investors

Impilo, a Philadelphia-based innovator in the digital health sector, has successfully secured a major strategic investment, bringing its total capital raised to $11.5M. This latest financing round, which saw a recent funding amount of $11.5M, underscores the growing market demand for robust infrastructure capable of managing the complexities of modern medical device distribution. By streamlining the logistical hurdles inherent in remote patient monitoring and digital health delivery, Impilo is positioning itself as a critical middleware provider for the evolving healthcare ecosystem.

The company's ability to attract significant backing in a competitive landscape highlights its unique value proposition. As healthcare providers increasingly shift toward decentralized care models, the necessity for seamless device integration has become paramount. Impilo's recent capital infusion serves as a testament to its operational maturity and its potential to scale within the enterprise healthtech market.

What is Impilo?

Impilo

Software

Healthcare Software

Founded in 2020, Impilo provides a sophisticated API infrastructure solution designed to automate the supply chain operations of digital health devices. The platform acts as a foundational layer for healthcare stakeholders, enabling them to buy, distribute, support, and integrate a wide array of medical hardware. By abstracting the technical and logistical complexities of device management, Impilo allows healthcare organizations to focus on patient outcomes rather than the intricacies of hardware procurement and deployment. Its market position is defined by its role as an essential enabler for digital health companies looking to achieve operational efficiency at scale.

How much funding has Impilo raised?

Impilo has raised a total of $11.5M across 1 funding round:

2024

Series A

$11.5M

Series A (2024): $11.5M with participation from One Way Ventures, GC 1 Capital, and Construct Capital

Key Investors in Impilo

One Way Ventures

One Way Ventures is a venture capital firm dedicated to supporting immigrant founders in building high-impact global companies, emphasizing the belief that borders should not limit human potential.

GC 1 Capital

Undisclosed investor participating in the funding round.

Construct Capital

Construct Capital is a veteran-owned business based in Arlington, Texas, that leverages extensive operational experience to support high-growth ventures.

What's next for Impilo?

With this major enterprise-level funding, Impilo is poised to accelerate its product development roadmap and expand its market reach. The strategic allocation of these funds will likely focus on enhancing the platform's integration capabilities and strengthening its API infrastructure to support a broader range of medical devices. As the company transitions from its initial growth phase into a more mature scaling stage, it will likely prioritize partnerships with large-scale healthcare providers and digital health platforms. The focus remains on solidifying its role as the backbone of the digital health supply chain, ensuring that the next generation of remote care is supported by reliable, automated, and scalable infrastructure.

See full Impilo company page

See More Financial Insights